| Financial Year |
March 31 2023 |
| Monetary Funds |
155,140,504.55 |
| Held-for-trading Financial Assets |
2,010,286,672.29 |
| Notes Receivable |
211,470.00 |
| Accounts Receivable |
174,572,604.99 |
| Advances to Suppliers |
7,151,090.27 |
| Other Receivables |
40,633,106.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
154,854,607.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,496,815.67 |
| Total Current Assets |
3,221,184,858.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
532,164,997.80 |
| Investment Properties |
22,150,641.99 |
| Fixed Assetes |
589,915,949.93 |
| Under-construction Projects |
558,388,508.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
368,148,924.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,864,698.78 |
| Deferred Income Tax Assets |
32,062,811.39 |
| Other Non-Current Assets |
7,027,820.02 |
| Sub-Total of Non-Current Assets |
2,762,795,306.38 |
| Total Assets |
5,983,980,164.62 |
| Short-Term Loans |
702,517,638.89 |
| Trading Financial liabilities |
-- |
| Notes Payable |
35,534,187.57 |
| Accounts Payable |
50,736,647.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
102,473,605.45 |
| Taxes Payable |
38,774,053.46 |
| Interest Payable |
-- |
| Dividend Payable |
2,320,537.48 |
| Other payables |
200,884,924.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
62,695,952.79 |
| Other Current Liabilities |
581,135.53 |
| Sub-Total of Current Liabilities |
1,247,293,184.48 |
| Long-term Loans |
286,887,821.43 |
| Bonds Payable |
752,518,510.24 |
| Long-Term Accounts Payable |
2,600,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
36,279,432.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,257,252,735.16 |
| Total Liabilities |
2,504,545,919.64 |
| Paid-In Capital(Or Share Stock) |
530,190,974.00 |
| Capital Surplus |
476,536,120.33 |
| Surplus Reserve |
416,944,483.56 |
| LESS:Treasury Stock |
8,185,041.91 |
| Undistributed Profits |
1,877,565,503.36 |
| Minority Stockholder's Interest |
51,381,720.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,428,052,524.96 |
| Owner's Equity（Stockholder's Equity） |
3,479,434,244.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,983,980,164.62 |
